Test Price
2,800 AED✅ Home Collection Available
SLC12A2 Gene Next-Generation Sequencing (Genetic Test for Bartter Syndrome in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SLC12A2 لمتلازمة بارتر بتقنية التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | 2026 إرشادات هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited processing.
Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: يقدم هذا الاختبار دقة تشخيصية عالية مع حساسية 99.9%، وخدمة سحب منزلي معتمدة، وإرشاد طبي عبر الهاتف لتفسير النتائج. التحليل متوافق مع القانون الاتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية في الإمارات.
Test Overview
This Next-Generation Sequencing (NGS) test provides a comprehensive analysis of the SLC12A2 gene, which is associated with Bartter syndrome—a rare inherited renal tubular disorder causing electrolyte imbalances. It enables definitive molecular diagnosis, carrier testing, and informed family planning.
| Feature | Our Test (NGS) | Alternative (Sanger Single-Exon) |
|---|---|---|
| Technology | Next-Generation Sequencing – full gene, all exons & splice sites | Sanger sequencing limited to known hotspot mutations |
| Diagnostic Precision | 99.9% analytical sensitivity, detects novel variants | ~95% sensitivity, may miss rare or novel mutations |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Cost | 2800 AED | ~4500 AED (limited coverage) |
Physician Insight & Safety Protocol
“While a genetic diagnosis provides clarity, it must be correlated with clinical symptoms and electrolyte panels. I always emphasize that a multidisciplinary approach involving nephrology and genetics is essential. Please discuss your results thoroughly with your healthcare provider before making any decisions.”
— Dr. PRABHAKAR REDDY, DHA License No: 61713011
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Abrupt changes to potassium-sparing diuretics, NSAIDs, or electrolyte supplements can trigger life-threatening arrhythmias or severe dehydration in Bartter syndrome patients.
Safety Exclusion Criteria & Red Flags
- Active bleeding disorder or anticoagulant therapy; consult your physician before blood draw.
- Minors (<18 years) require legal guardian consent in compliance with UAE CDS Law 2026.
- Inability to provide adequate clinical history or family pedigree.
Emergency Red Flags
Seek immediate medical attention if you experience sudden muscle weakness, palpitations, fainting, or profound fatigue, as these may indicate severe hypokalemia or electrolyte crisis.
Patient FAQ & Clinical Guidance
1. What does this genetic test actually detect?
Snippet: This NGS test identifies pathogenic mutations in the entire SLC12A2 gene, confirming Bartter syndrome at a molecular level and enabling precise familial risk assessment.
سؤال: ما الذي يكشفه هذا الاختبار الجيني بدقة؟
إجابة: يكشف هذا الاختبار الطفرات الممرضة في كامل جين SLC12A2، مما يؤكد متلازمة بارتر على المستوى الجزيئي ويمكّن من تقييم دقيق للمخاطر العائلية.
2. How should I prepare for the blood collection?
Snippet: Complete a genetic counselling session, provide a detailed three-generation family pedigree, and maintain normal hydration; no fasting is required.
سؤال: كيف أستعد لعملية سحب العينة الدموية؟
إجابة: أكمل جلسة استشارة وراثية، وقدم شجرة عائلة مفصلة لثلاثة أجيال، وحافظ على ترطيب طبيعي؛ لا يلزم الصيام.
3. Is this test approved by UAE health authorities?
Snippet: Yes, it is performed in a DHA-licensed facility (License 9834453) under ISO 9001:2015, fully adherent to Federal Decree-Law No. 41 of 2024 and UAE PDPL.
سؤال: هل هذا الاختبار معتمد من هيئات الصحة في الإمارات؟
إجابة: نعم، يتم إجراؤه في منشأة مرخصة من هيئة الصحة بدبي (رقم الترخيص 9834453) وفق مواصفة ISO 9001:2015، ومتوافق تمامًا مع القانون الاتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية.
Pre- Requirement: A detailed clinical history and a formal genetic counselling session to construct a three-generation pedigree are mandatory prior to sample collection. Samples accepted: Whole blood (EDTA), extracted DNA, or one drop of blood on FTA card. Turnaround time: 3–4 weeks post-receipt of sample.
UAE Data Privacy & Compliance: All genetic data is protected under UAE Personal Data Protection Law and processed exclusively in an ISO 9001:2015 certified facility. For appointment booking or insurance inquiries, contact us on WhatsApp +971 54 548 8731 (8 AM – 11 PM, 7 days a week).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians